Clinical and Radiographic Evaluation of Implant Stability in Healed Maxillary Posterior Sites Com… (NCT06599112) | Clinical Trial Compass
RecruitingNot Applicable
Clinical and Radiographic Evaluation of Implant Stability in Healed Maxillary Posterior Sites Comparing Osteotome, Osseodensification and Conventional Drilling Implant Placement Techniques
Egypt36 participantsStarted 2024-09
Plain-language summary
This study aims to compare the implant stability values following implant placement via Osteotomes and via Osseodensification using Densah Burs versus implant placement using conventional drilling technique in patients with upper posterior partially edentulous ridges as well as evaluating the crestal bone loss around temporary restorations following the three compared drilling techniques.
Who can participate
Age range
25 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with an age range of 25-70 years
* Patients with systemic health
* Patient with missing teeth in the upper posterior area
* Patients with D3 or D4 type of alveolar bone
* Healed bony sites with sufficient dimension for implant placement
* Vertical height (≥ 10 mm)
* Bucco-lingual dimension (≥ 5.5 mm)
* Mesio-distal width (≥6.5 mm)
* Patients with periodontal health (PD \< 4mm, BOP \< 10%)
* Inter-arch space of 7.5 to allow implant restoration
* Good oral hygiene
* Cooperative patients who accepted the trial follow up period and sign the informed consent
Exclusion Criteria:
* Pregnant females
* Smokers
* Patients with habits that may compromise the longevity and affect the result of the implant as alcoholism or parafunctional habits
* History of radiotherapy or use of bisphosphonates
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Implant stability.
Timeframe: Will take place at same day,1,2,3,4,6,8 ,12and 16 weeks postoperatively.